Conference Coverage
Latest News
Depression strikes more than half of obese adolescents
New study suggests an association between multiple components of metabolic syndrome and depression in obese teens.
Conference Coverage
Peripheral muscle fatigue limits post-COVID exercise
Cardiopulmonary exercise testing suggests need for aerobic and muscle strengthening after COVID-19.
Conference Coverage
Combo of SGLT2 inhibitor + GLP-1 RA boosts diabetes survival
Survival of patients with type 2 diabetes and CVD rose by 80% when they received both an SGLT2 inhibitor and GLP-1 RA, compared with either class...
Conference Coverage
Better survival in older cancer patients who take metformin
“It is important to explore optimal dosages that significantly improve cancer outcomes to boost anticancer effect.”
Conference Coverage
High comorbidity rate seen before osteoarthritis diagnosis
More than 40 medical conditions were positively associated with having a new diagnosis of osteoarthritis in a large, nested case-control study.
Conference Coverage
Empagliflozin rapidly improves acute heart failure symptoms in hospitalized patients
Empagliflozin showed symptomatic benefits in patients hospitalized for acute heart failure after 2 weeks in a secondary analysis from the EMPULSE...
Conference Coverage
Renal denervation BP benefits remain at 3 years: SPYRAL HTN-ON
Results from the sham-controlled trial suggest renal denervation may provide an alternative “adjunctive treatment” in the management of...
Conference Coverage
Type 2 diabetes remission possible for those with lower BMI
Having a normal BMI is no barrier to experiencing type 2 diabetes remission with a structured weight-loss program, show U.K. results.
Latest News
Could AI tool identify type 1 diabetes earlier in childhood?
In the U.K., approximately 25% of children with type 1 diabetes are diagnosed while they are in diabetic ketoacidosis, a figure that has remained...
Conference Coverage
Early PCSK9 inhibition in AMI yields plaque regression
‘Go early and go low’ is an expert’s response to the imaging results from PACMAN-AMI showing plaque reduction after AMI patients received...
Conference Coverage
APOLLO: SLN360 clears first major hurdle, hammering Lp(a)
The results add to growing enthusiasm for achieving the ‘holy grail’ of a lipoprotein(a)-specific lowering agent, but whether it will reduce...